The bitcoin of Biotech is about to go down

Singkat

CRISPR Therapeutics AG (NASDAQ:CRSP)

Telah dikemas kini

NASDAQ:CRSP CRISPR Therapeutics AG

I view CRSP as one of the most interesting biotechnology stocks out there. DYOR. If it works, it will be huge. I am happy to see there will be opportunities to accumulate some stock, after I short it into my ideal entry levels.

Komen:

approaching target 1

Komen:

CRSP is in long term accumulation zone. It's a buy anywhere between 32 - 24 as a long term hold.

Komen:

This trade did extremely well from an execution standpoint. The technicals are now indicating to me that price may reach close to $200 per share in the next year or two. This stock has all the signs of being a superior long term hold.

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.